Geneos Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.33M | Buy |
5,928
+5,682
| +2,310% | +$3.64M | 0.08% | 275 |
|
|
2025
Q4 | $166K | Sell |
246
-22
| -8% | -$15K | ﹤0.01% | 982 |
|
|
2025
Q3 | $171K | Sell |
268
-111
| -29% | -$67.4K | ﹤0.01% | 953 |
|
|
2025
Q2 | $203K | Sell |
379
-370
| -49% | -$177K | 0.01% | 988 |
|
|
2025
Q1 | $315K | Buy |
749
+507
| +210% | +$220K | ﹤0.01% | 1064 |
|
|
2024
Q4 | $100K | Sell |
242
-11
| -4% | -$4.83K | ﹤0.01% | 1068 |
|
|
2024
Q3 | $128K | Buy |
253
+48
| +23% | +$23.3K | ﹤0.01% | 888 |
|
|
2024
Q2 | $99.8K | Sell |
205
-9
| -4% | -$4.52K | ﹤0.01% | 869 |
|
|
2024
Q1 | $115K | Sell |
214
-807
| -79% | -$441K | 0.01% | 819 |
|
|
2023
Q4 | $567K | Sell |
1,021
-13
| -1% | -$6.1K | 0.03% | 456 |
|
|
2023
Q3 | $452K | Sell |
1,034
-278
| -21% | -$139K | 0.02% | 486 |
|
|
2023
Q2 | $659K | Sell |
1,312
-224
| -15% | -$107K | 0.03% | 404 |
|
|
2023
Q1 | $768K | Sell |
1,536
-307
| -17% | -$147K | 0.05% | 350 |
|
|
2022
Q4 | $752K | Buy |
1,843
+37
| +2% | +$14.4K | 0.05% | 334 |
|
|
2022
Q3 | $588K | Buy |
1,806
+388
| +27% | +$143K | 0.04% | 359 |
|
|
2022
Q2 | $508K | Buy |
1,418
+46
| +3% | +$18.8K | 0.03% | 489 |
|
|
2022
Q1 | $750K | Buy |
1,372
+365
| +36% | +$192K | 0.03% | 436 |
|
|
2021
Q4 | $663K | Buy |
1,007
+9
| +0.9% | +$5.65K | 0.03% | 498 |
|
|
2021
Q3 | $622K | Sell |
998
-43
| -4% | -$28.9K | 0.02% | 515 |
|
|
2021
Q2 | $674K | Sell |
1,041
-58
| -5% | -$32K | 0.03% | 477 |
|
|
2021
Q1 | $603K | Sell |
1,099
-13
| -1% | -$6.51K | 0.02% | 585 |
|
|
2020
Q4 | $509K | Buy |
1,112
+548
| +97% | +$245K | 0.02% | 531 |
|
|
2020
Q3 | $213K | Sell |
564
-85
| -13% | -$31.4K | 0.01% | 672 |
|
|
2020
Q2 | $210K | Sell |
649
-85
| -12% | -$24.6K | 0.01% | 653 |
|
|
2020
Q1 | $170K | Buy |
734
+283
| +63% | +$73.9K | 0.01% | 663 |
|
|
2019
Q4 | $119K | Buy |
451
+374
| +486% | +$98.6K | 0.01% | 883 |
|
|
2019
Q3 | $20K | Sell |
77
-30
| -28% | -$8.35K | ﹤0.01% | 1606 |
|
|
2019
Q2 | $29K | Hold |
107
| – | – | ﹤0.01% | 1453 |
|
|
2019
Q1 | $23K | Buy |
107
+95
| +792% | +$19.6K | ﹤0.01% | 1501 |
|
|
2018
Q4 | $2K | Hold |
12
| – | – | ﹤0.01% | 2201 |
|
|
2018
Q3 | $2K | Hold |
12
| – | – | ﹤0.01% | 2256 |
|
|
2018
Q2 | $2K | Hold |
12
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q1 | $2K | Hold |
12
| – | – | ﹤0.01% | 2035 |
|
|
2017
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 2104 |
|
|
2017
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 2049 |
|
|
2017
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 2001 |
|
|
2017
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 1988 |
|
|
2016
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 1962 |
|
|
2016
Q3 | $1K | Buy |
+12
| New | +$1.26K | ﹤0.01% | 1887 |
|
Other funds holding IDXX
VCM
VPM
Geneos Wealth Management's IDXX Position: Q1 2026 in Review
Geneos Wealth Management increased its Idexx Laboratories (IDXX) stake by 2,310% in Q1 2026, buying an estimated $3.64M and bringing the position to 5,928 shares worth $3.33M. The position accounts for 0.08% of the portfolio, ranked #275.
Geneos Wealth Management first reported a position in IDXX in Q3 2016 and has held it in 39 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Geneos Wealth Management held 5,928 shares of Idexx Laboratories worth $3.33M as of Q1 2026.
- Geneos Wealth Management bought 5,682 Idexx Laboratories shares in Q1 2026, an estimated $3.64M.
- Idexx Laboratories made up 0.08% of Geneos Wealth Management's portfolio in Q1 2026, its #275 holding.
- Geneos Wealth Management first reported a position in Idexx Laboratories in Q3 2016 and has held it in 39 quarters since.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.